Skip to content

Neuronetics STIM Asset turnover

Asset turnover at other companies

LifeStance Health Group logo
LifeStance Health GroupLFST
0.7×+0.1×
Stereotaxis logo
StereotaxisSTXS
0.6×0.0×
Neuropace, Inc. logo
Neuropace, Inc.NPCE
+0.1×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
0.7×0.0×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
0.7×-0.1×
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
0.0×

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-59.6%
Enterprise value$162.64M-44.6%
P/S0.6×-1.4×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Calculated from Neuronetics’s reported figures.

Based on trailing twelve months.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's asset turnover?
Neuronetics (STIM) reported asset turnover of 1.1× in Q1 2026.
How has Neuronetics's asset turnover changed year-over-year?
Neuronetics's asset turnover increased by 55.8% year-over-year, from 0.7× to 1.1×.
What is the long-term trend for Neuronetics's asset turnover?
Over 5 years (2020 to 2025), Neuronetics's asset turnover has grown at a 13.9% compound annual growth rate (CAGR), from 0.6× to 1.1×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.